WGRX
Wellgistics Health, Inc.
NASDAQ · Healthcare · Medical - Distribution · US
$3.52
+0.00%Price chart
Jun 29Jul 2Jul 8Jul 13Jul 16Jul 21Jul 24Jul 29
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−8.4x
Market Cap
$445.82M
MomentumView details →
1D Return
+0.00%
YTD Return
−84.83%
RSI (14)
46.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−8.4x
Market Cap
$445.82M
RSI (14)
46.3
MomentumView details →
1D Return
+0.00%
YTD Return
−84.83%
SummaryUpdated Jun 1, 2026
Wellgistics Health, Inc. (NASDAQ:WGRX) is a pharmaceutical distribution company that went public in February 2025. The company was incorporated in 2022 and was formerly known as Danam Health, Inc. before changing its name in October 2024. Based in Tampa, Florida, Wellgistics operates as a wholesaler and distributor serving pharmaceutical manufacturers and independent retail pharmacies across the United States. The company has grown rapidly since its founding, expanding from generating $32.8 million in revenue in 2022 to $18.1 million in 2024, though recent quarters have shown operational challenges as the company scales its business model.
Similar companies
Latest newsMore news →
Wellgistics Health executives Suren Ajjarapu and Prashant Patel exercised warrants to acquire 200,000 common shares at $10 per share.66d agoWellgistics Health, Inc. signed a 2026 PIPE financing agreement on May 27, 2026, issuing convertible promissory notes and warrants to accredited investors for gross proceeds of $16,906,250, with notes convertible into Series A Convertible Preferred Stock and then common stock.99d ago